Research Article
Influence of Enhanced Recovery Pathway on Surgical Site Infection after Colonic Surgery
Table 1
Baseline characteristics.
| | All patients () | SSI () | No SSI () | |
| | Age (years) (mean ± SD) | 64 ± 16 | 66 ± 15 | 64 ± 16 | 0.395 | | Gender | | | | | | Male (%) | 186 (47) | 24 (44) | 162 (47) | 0.703 | | BMI (kg/m2) | | | | | | >25 (%) | 212 (53) | 31 (57) | 181 (53) | 0.525 | | ASA group | | | | | | I-II (%) | 258 (65) | 35 (65) | 223 (65) | 0.977 | | III-IV (%) | 139 (35) | 19 (35) | 120 (33) | | Smoking (%) | 75 (19) | 12 (22) | 63 (18) | 0.051 | | Diabetes (%) | 48 (13) | 6 (11) | 42 (12) | 0.765 | | Immunosuppression (%) | 47 (12) | 5 (9) | 42 (12) | 0.528 | | Neoadjuvant chemotherapy (%) | 26 (7) | 3 (6) | 24 (7) | 0.696 | | Previous abdominal surgery (%) | 129 (33) | 25 (46) | 104 (30) | 0.005 | | Malignancy (%) | 210 (53) | 35 (65) | 175 (51) | 0.215 | | Diagnosis (%) | | | | | | Primary adenocarcinoma | 179 (45) | 18 (33) | 161 (47) | 0.491 | | Other primary malignancy | 7 (2) | 1 (2) | 6 (2) | | | Metastatic disease | 13 (3) | 4 (7) | 9 (2) | | | Benign tumor/polyp | 22 (6) | 2 (4) | 20 (6) | | | Inflammatory bowel disease | 26 (6) | 5 (9) | 21 (6) | | | Diverticular disease | 90 (23) | 15 (28) | 75 (22) | | | Functional disorder | 28 (7) | 4 (7) | 24 (7) | | | Other benign disorder | 32 (8) | 5 (10) | 27 (8) | |
|
|
SSI: surgical site infection; BMI: body mass index; ASA: American Society of Anaesthesiologists. Significant values are indicated in bold characters.
|
